Individuals who had childhood epilepsy have an increased accumulation of brain amyloid later in life, potentially ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, a new study indicates.

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Think your brain is too old to learn new tricks, let alone keep cognitive decline at bay? Think again. Research featured in the journal Cell Stem Cell in 2019 revealed that neurons continue to form in ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

ProMIS Neurosciences Inc., a clinical-stage biopharmaceutical company, made significant disclosures in its recent 8-K filing with the Securities and Exchange Commission. In its filing dated January 27 ...

Prolonged rapid eye movement (REM) sleep latency was linked with Alzheimer's disease biomarkers, cross-sectional data showed.

This accumulation could elevate their risk of developing late-onset amyloid-related disorders, such as Alzheimer’s disease.

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...